- conflicts or gaps
- [[{"field": {"value": "identity.founded_year", "source_urls": ["https://www.ycombinator.com/companies/gen1e-lifesciences", "https://www.linkedin.com/company/gen1e-lifesciences", "https://bsmedia.business-standard.com/_media/bs/data/announcements/bse/21102025/ae4768b0-a159-45af-99b0-d2f87270d920.pdf"]}, "issue": {"value": "YC and UM Ventures cite 2018 founding; LinkedIn company profile lists founded 2019; Rubicon BSE filing cites incorporation May 2, 2018.", "source_urls": ["https://www.ycombinator.com/companies/gen1e-lifesciences", "https://www.linkedin.com/company/gen1e-lifesciences", "https://bsmedia.business-standard.com/_media/bs/data/announcements/bse/21102025/ae4768b0-a159-45af-99b0-d2f87270d920.pdf"]}}, {"field": {"value": "founders", "source_urls": ["https://www.ycombinator.com/companies/gen1e-lifesciences", "https://www.fiercebiotech.com/biotech/meet-gen1e-biotech-bringing-p38alpha-kinase-drugs-to-inflammatory-diseases", "https://www.gen1e.com/about"]}, "issue": {"value": "YC lists only Ritu Lal as Founder; Fierce Biotech and LinkedIn identify Clint Webb as co-founder (departed 2019); company about page lists Soujanya Bhumkar as AI/ML platform co-founder.", "source_urls": ["https://www.ycombinator.com/companies/gen1e-lifesciences", "https://www.fiercebiotech.com/biotech/meet-gen1e-biotech-bringing-p38alpha-kinase-drugs-to-inflammatory-diseases", "https://www.gen1e.com/about"]}}, {"field": {"value": "funding.total_raised_usd", "source_urls": ["https://www.linkedin.com/company/gen1e-lifesciences", "https://www.cbinsights.com/company/gen1e-lifesciences/financials", "https://tracxn.com/d/companies/gen1e/__jGJ6jGs6EzrZnfRm_I4QqiUJBUwCgn0IWJYoXbMbKL4", "https://www.umventures.org/news/umvb-announces-investment-gen1e-lifesciences"]}, "issue": {"value": "Total funding varies: LinkedIn $17.0M, CB Insights/Tracxn ~$22.7M, PitchBook $25.5M, UM Ventures >$21M seed; no audited primary total found.", "source_urls": ["https://www.linkedin.com/company/gen1e-lifesciences", "https://www.cbinsights.com/company/gen1e-lifesciences/financials", "https://tracxn.com/d/companies/gen1e/__jGJ6jGs6EzrZnfRm_I4QqiUJBUwCgn0IWJYoXbMbKL4", "https://www.umventures.org/news/umvb-announces-investment-gen1e-lifesciences"]}}, {"field": {"value": "funding.rounds[4].amount_usd", "source_urls": ["https://bsmedia.business-standard.com/_media/bs/data/announcements/bse/21102025/ae4768b0-a159-45af-99b0-d2f87270d920.pdf", "https://www.cbinsights.com/company/gen1e-lifesciences/financials"]}, "issue": {"value": "Rubicon BSE filing states up to $3M Series Prime investment; CB Insights reports $5.52M corporate minority on 2025-10-21 for same period.", "source_urls": ["https://bsmedia.business-standard.com/_media/bs/data/announcements/bse/21102025/ae4768b0-a159-45af-99b0-d2f87270d920.pdf", "https://www.cbinsights.com/company/gen1e-lifesciences/financials"]}}, {"field": {"value": "employees.snapshots", "source_urls": ["https://www.fiercebiotech.com/biotech/meet-gen1e-biotech-bringing-p38alpha-kinase-drugs-to-inflammatory-diseases", "https://www.linkedin.com/company/gen1e-lifesciences", "https://yc-oss.github.io/api/batches/summer-2019/gen1e-lifesciences.json"]}, "issue": {"value": "Fierce Biotech (Apr 2022) cites ~10 part-time consultants; LinkedIn lists 15 employees; YC OSS team_size is null.", "source_urls": ["https://www.fiercebiotech.com/biotech/meet-gen1e-biotech-bringing-p38alpha-kinase-drugs-to-inflammatory-diseases", "https://www.linkedin.com/company/gen1e-lifesciences", "https://yc-oss.github.io/api/batches/summer-2019/gen1e-lifesciences.json"]}}, {"field": {"value": "products.platform.name", "source_urls": ["https://gen1elifesci.com/", "https://www.prnewswire.com/news-releases/gen1e-lifesciences-announces-partnership-with-barda-to-advance-its-ai-powered-endotyping-program-for-ards-patients-to-further-accelerate-its-novel-lead-compound-gen-1124-301965308.html"]}, "issue": {"value": "Company uses both GRID (website, Jun 2026 press) and RIDGE (Oct 2023 BARDA press release) for its integrated AI platform.", "source_urls": ["https://gen1elifesci.com/", "https://www.prnewswire.com/news-releases/gen1e-lifesciences-announces-partnership-with-barda-to-advance-its-ai-powered-endotyping-program-for-ards-patients-to-further-accelerate-its-novel-lead-compound-gen-1124-301965308.html"]}}, {"field": {"value": "identity.website", "source_urls": ["https://www.gen1e.com/about", "https://gen1elifesci.com/"]}, "issue": {"value": "Two active domains (gen1e.com and gen1elifesci.com) both host company content; YC lists gen1e.com as primary website.", "source_urls": ["https://www.ycombinator.com/companies/gen1e-lifesciences", "https://gen1elifesci.com/", "https://www.gen1e.com/about"]}}, {"field": {"value": "funding.rounds[2].amount_usd", "source_urls": ["https://www.sec.gov/Archives/edgar/data/1752886/000175288622000002/0001752886-22-000002-index.html", "https://www.linkedin.com/company/gen1e-lifesciences"]}, "issue": {"value": "SEC Form D filed 2022-12-21 confirms exempt offering but filing amount not verified; LinkedIn secondary data cites $17.0M Series A on same date.", "source_urls": ["https://www.sec.gov/Archives/edgar/data/1752886/000175288622000002/0001752886-22-000002-index.html", "https://www.linkedin.com/company/gen1e-lifesciences"]}}]]
- source urls
- ["https://bsmedia.business-standard.com/_media/bs/data/announcements/bse/21102025/ae4768b0-a159-45af-99b0-d2f87270d920.pdf", "https://finance.yahoo.com/sectors/healthcare/articles/us-fda-grants-orphan-drug-110000286.html", "https://gen1elifesci.com/", "https://tracxn.com/d/companies/gen1e/__jGJ6jGs6EzrZnfRm_I4QqiUJBUwCgn0IWJYoXbMbKL4", "https://www.biospace.com/press-releases/us-fda-grants-orphan-drug-and-rare-pediatric-disease-designations-to-gen1e-lifesciences-dual-signal-modulator-for-the-treatment-of-duchenne-muscular-dystrophy", "https://www.businesswire.com/news/home/20260421970691/en/GEn1E-and-Rubicon-Research-Announce-Strategic-Partnership-to-Advance-AI-Driven-Precision-Immunomodulators", "https://www.cbinsights.com/company/gen1e-lifesciences", "https://www.cbinsights.com/company/gen1e-lifesciences/financials", "https://www.fiercebiotech.com/biotech/meet-gen1e-biotech-bringing-p38alpha-kinase-drugs-to-inflammatory-diseases", "https://www.gen1e.com/about", "https://www.gen1e.com/differentiation", "https://www.gen1e.com/phase-2-study", "https://www.linkedin.com/company/gen1e-lifesciences", "https://www.linkedin.com/in/clintwebb", "https://www.linkedin.com/in/dr-ritulal", "https://www.prnewswire.com/news-releases/gen1e-lifesciences-announces-partnership-with-barda-to-advance-its-ai-powered-endotyping-program-for-ards-patients-to-further-accelerate-its-novel-lead-compound-gen-1124-301965308.html", "https://www.sec.gov/Archives/edgar/data/1752886/000175288622000002/0001752886-22-000002-index.html", "https://www.umventures.org/news/umvb-announces-investment-gen1e-lifesciences", "https://www.ycombinator.com/companies/gen1e-lifesciences", "https://yc-oss.github.io/api/batches/summer-2019/gen1e-lifesciences.json"]